Resorbable Magnesium Scaffolds Registry
ConditionCoronary Artery Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBiotronik AG
About this trial
The registry follows the ESC/EACTS guideline and further investigates the clinical performance and short-term safety of RMS (Resorbable Magnesium Scaffolds) in a real world setting within the scope of its intended use without further (medical related) exclusion criteria according to their respective instructions for use (IFU).
Eligibility criteria
Qualifiers
According to the IFU
Disqualifiers
According to the IFU
Trial design
Treatments tested in this trial
- Magmaris
- Freesolve
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov